US Patent 7232797 Erythropoietin dosing regimen for treating anemia
Patent 7232797 was granted and assigned to Ortho-McNeil Pharmaceutical on June, 2007 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7232797 Erythropoietin dosing regimen for treating anemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.